25.11.2024 • Sponsored • WhitepaperBiesterfeldChemical Distribution

Excellence in Pharmaceutical Distribution and the Critical Role of Good Distribution Practice (GDP)

Discover in our exclusive whitepaper how compliance with Good Distribution Practice (GDP) contributes significantly to the safety of pharmaceuticals. Learn how companies in the pharmaceutical industry can improve their raw material sourcing through a strategic partnership with a distributor – efficiently, cost-effectively and reliably.

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Content of the Whitepaper

  • Basics of GDP for pharmaceutical raw materials: Get to know the core principles.
  • Importance of GDP guidelines: Understand the significance and how they are implemented in practice.
  • Administrative and logistical requirements of GDP: Get an overview of the most important processes.
  • Added value through expertise: Optimize your processes with a distributor’s advice, quality assurance, and regulatory know-how.

Further Information

Chemical distributors are an indispensable link in the supply chain of the processing industry, especially when it comes to the provision of raw materials.

However, in the strictly regulated pharmaceutical industry, their importance goes far beyond the traditional tasks of buying and selling. They are instrumental in ensuring logistical efficiency, cost reduction, quality assurance, and technical advice. Through these diverse services, they make a decisive contribution to maintaining smooth production processes and adherence to high-quality standards.

Unlock the Full Potential of Your Pharmaceutical Supply Chain

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals. Learn how strategic partnerships with expert distributors can revolutionize your raw material sourcing-making it more efficient, cost-effective, and reliable.

Download this free whitepaper

Company

Logo:

Biesterfeld AG

Ferdinandstraße 41
20095 Hamburg
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read